Association between marijuana exposure and pulmonary function over 20 years
- PMID: 22235088
- PMCID: PMC3840897
- DOI: 10.1001/jama.2011.1961
Association between marijuana exposure and pulmonary function over 20 years
Abstract
Context: Marijuana smoke contains many of the same constituents as tobacco smoke, but whether it has similar adverse effects on pulmonary function is unclear.
Objective: To analyze associations between marijuana (both current and lifetime exposure) and pulmonary function.
Design, setting, and participants: The Coronary Artery Risk Development in Young Adults (CARDIA) study, a longitudinal study collecting repeated measurements of pulmonary function and smoking over 20 years (March 26, 1985-August 19, 2006) in a cohort of 5115 men and women in 4 US cities. Mixed linear modeling was used to account for individual age-based trajectories of pulmonary function and other covariates including tobacco use, which was analyzed in parallel as a positive control. Lifetime exposure to marijuana joints was expressed in joint-years, with 1 joint-year of exposure equivalent to smoking 365 joints or filled pipe bowls.
Main outcome measures: Forced expiratory volume in the first second of expiration (FEV(1)) and forced vital capacity (FVC).
Results: Marijuana exposure was nearly as common as tobacco exposure but was mostly light (median, 2-3 episodes per month). Tobacco exposure, both current and lifetime, was linearly associated with lower FEV(1) and FVC. In contrast, the association between marijuana exposure and pulmonary function was nonlinear (P < .001): at low levels of exposure, FEV(1) increased by 13 mL/joint-year (95% CI, 6.4 to 20; P < .001) and FVC by 20 mL/joint-year (95% CI, 12 to 27; P < .001), but at higher levels of exposure, these associations leveled or even reversed. The slope for FEV(1) was -2.2 mL/joint-year (95% CI, -4.6 to 0.3; P = .08) at more than 10 joint-years and -3.2 mL per marijuana smoking episode/mo (95% CI, -5.8 to -0.6; P = .02) at more than 20 episodes/mo. With very heavy marijuana use, the net association with FEV(1) was not significantly different from baseline, and the net association with FVC remained significantly greater than baseline (eg, at 20 joint-years, 76 mL [95% CI, 34 to 117]; P < .001).
Conclusion: Occasional and low cumulative marijuana use was not associated with adverse effects on pulmonary function.
Conflict of interest statement
Besides the federal funding listed above, the authors have no other conflicts of interest to report.
Figures
Comment in
-
Long-term marijuana use and pulmonary function.JAMA. 2012 May 2;307(17):1796; author reply 1796-7. doi: 10.1001/jama.2012.3570. JAMA. 2012. PMID: 22550189 No abstract available.
Similar articles
-
The Puzzle of Marijuana Use and Forced Vital Capacity.Ann Am Thorac Soc. 2024 May;21(5):683-691. doi: 10.1513/AnnalsATS.202312-1010CME. Ann Am Thorac Soc. 2024. PMID: 38271695 Free PMC article. Review.
-
The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and Nutrition Examination Study.Ann Am Thorac Soc. 2015 Feb;12(2):135-41. doi: 10.1513/AnnalsATS.201407-333OC. Ann Am Thorac Soc. 2015. PMID: 25521349 Free PMC article.
-
Lifetime marijuana use and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults (CARDIA) study.Addiction. 2018 May;113(5):845-856. doi: 10.1111/add.14110. Epub 2018 Jan 21. Addiction. 2018. PMID: 29168268
-
Association Between Lifetime Marijuana Use and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.JAMA Intern Med. 2016 Mar;176(3):352-61. doi: 10.1001/jamainternmed.2015.7841. JAMA Intern Med. 2016. PMID: 26831916 Free PMC article.
-
Effect of cannabis smoking on lung function and respiratory symptoms: a structured literature review.NPJ Prim Care Respir Med. 2016 Oct 20;26:16071. doi: 10.1038/npjpcrm.2016.71. NPJ Prim Care Respir Med. 2016. PMID: 27763599 Free PMC article. Review.
Cited by
-
Airway Mucus Plugs in Community-Living Adults: A Study Protocol.J Clin Exp Pathol. 2024;14(3):492. Epub 2024 May 24. J Clin Exp Pathol. 2024. PMID: 39360267 Free PMC article.
-
Airway Mucus Plugs in Community-Living Adults: A Study Protocol.medRxiv [Preprint]. 2024 May 16:2024.05.15.24307439. doi: 10.1101/2024.05.15.24307439. medRxiv. 2024. Update in: J Clin Exp Pathol. 2024;14(3):492. PMID: 38798504 Free PMC article. Updated. Preprint.
-
The Puzzle of Marijuana Use and Forced Vital Capacity.Ann Am Thorac Soc. 2024 May;21(5):683-691. doi: 10.1513/AnnalsATS.202312-1010CME. Ann Am Thorac Soc. 2024. PMID: 38271695 Free PMC article. Review.
-
Genome-wide DNA methylation association study of recent and cumulative marijuana use in middle aged adults.Mol Psychiatry. 2023 Jun;28(6):2572-2582. doi: 10.1038/s41380-023-02106-y. Epub 2023 May 31. Mol Psychiatry. 2023. PMID: 37258616 Free PMC article.
-
Impact of Marijuana Smoking on COPD Progression in a Cohort of Middle-Aged and Older Persons.Chronic Obstr Pulm Dis. 2023 Jul 26;10(3):234-247. doi: 10.15326/jcopdf.2022.0378. Chronic Obstr Pulm Dis. 2023. PMID: 37199732 Free PMC article.
References
-
- Kamholz SL. Pulmonary and cardiovascular consequences of smoking. Med Clin North Am. 2004 Nov;88(6):1415–1430. ix–x. - PubMed
-
- Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD) Lancet. 2004 Aug 14–20;364(9434):613–620. - PubMed
-
- National Center for Health Statistics. Number of deaths from each cause, by 10-year age groups, race, and sex: United States, 2005. [accessed Nov 30, 2011]; Available at http://205.207.175.93/VitalStats/TableViewer/tableView.aspx?ReportId=26044.
-
- Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States. JAMA. 2000 2004 Mar 10;291(10):1238–1245. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
